[go: up one dir, main page]

UA107803C2 - DOSAGE FORM OF IRON CITRATE (iii) - Google Patents

DOSAGE FORM OF IRON CITRATE (iii)

Info

Publication number
UA107803C2
UA107803C2 UAA201202006A UAA201202006A UA107803C2 UA 107803 C2 UA107803 C2 UA 107803C2 UA A201202006 A UAA201202006 A UA A201202006A UA A201202006 A UAA201202006 A UA A201202006A UA 107803 C2 UA107803 C2 UA 107803C2
Authority
UA
Ukraine
Prior art keywords
iii
dosage form
iron citrate
iron
citrate
Prior art date
Application number
UAA201202006A
Other languages
English (en)
Ukrainian (uk)
Inventor
Henry Trong Le
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Priority claimed from PCT/US2010/042788 external-priority patent/WO2011011541A1/en
Publication of UA107803C2 publication Critical patent/UA107803C2/ru

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UAA201202006A 2009-07-21 2010-07-21 DOSAGE FORM OF IRON CITRATE (iii) UA107803C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27712409P 2009-07-21 2009-07-21
PCT/US2010/042788 WO2011011541A1 (en) 2009-07-21 2010-07-21 Ferric citrate dosage forms

Publications (1)

Publication Number Publication Date
UA107803C2 true UA107803C2 (en) 2015-02-25

Family

ID=52989819

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201202006A UA107803C2 (en) 2009-07-21 2010-07-21 DOSAGE FORM OF IRON CITRATE (iii)

Country Status (1)

Country Link
UA (1) UA107803C2 (ru)

Similar Documents

Publication Publication Date Title
TW201711676A (en) Ferric citrate dosage forms
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
IN2015DN01156A (ru)
MX2019011905A (es) Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica.
IN2012DN02805A (ru)
MY170713A (en) Treatment protocol of diabetes type 2
MX2015007916A (es) Peri-carbinoles.
MY149028A (en) Nalmefene hydrochloride dihydrate
EA201200574A1 (ru) Терапия пирфенидоном и индукторы цитохрома р450
PH12014501032A1 (en) 2-thiopyrimidinones
TN2012000457A1 (en) Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
PH12014502558A1 (en) Drug for preventing and/or treating polycystic kidney disease
MX2012001306A (es) Inhibicion de matastasis de tumor.
MY197209A (en) Uses of benzimidazole derivative for nocturnal acid breakthrough
GB201303865D0 (en) Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein
PH12016500903A1 (en) Novel methods for treating neurodegenerative diseases
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
MY166555A (en) Substituted piperidine
PH12014502065A1 (en) Vesicular formulations
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
MX2017004723A (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
NZ703573A (en) Feijoa fruit extract
UA107803C2 (en) DOSAGE FORM OF IRON CITRATE (iii)
MX2015013736A (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemia por deficiencia de hierro.
IN2014DN07989A (ru)